9 out of 10 patients with CINV report an impact on their daily life – Chugai Pharma Europe

Chugai Pharma Europe shared on LinkedIn: 

“Did you know 9 out of 10 patients with chemotherapy-induced nausea and vomiting (CINV) report an impact on their daily life?

Alongside the physical and emotional burden faced by cancer patients, side effects like CINV can have a long-lasting effect on wellbeing.

Some patients may even consider stopping their chemotherapy due to CINV symptoms.

That’s why we are on a mission to deliver comprehensive cancer care, underpinned by Supportive Care.

Working with the healthcare community to provide resources and support that empower patients to manage their symptoms, and feel more in control of their wellbeing.

1. Ballatori E et al. Support Care Cancer 2007:15(2):179–85.
2. Bhandari PR. J Adv Pharm Technol Res. 2012 Oct-Dec; 3(4): 202–209.”

Source: Chugai Pharma Europe/LinkedIn